Alternative splicing in cancer: Noise, functional, or systematic?

International Journal of Biochemistry and Cell Biology

Volumn 39, Issue 7-8, 2007, Pages 1432-1449

  Skotheim, Rolf I ^a,b   Nees, Matthias ^c  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

^c VTT TECHNICAL RESEARCH CENTRE OF FINLAND   (Finland)

Author keywords

Alternative splicing of mRNAs; Cancer progression; Pre mRNA processing; Systems biology

Indexed keywords

HERMES ANTIGEN;

BIOCHEMISTRY; CANCER CELL; CANCER GROWTH; CANCER RESEARCH; CYTOLOGY; GENE EXPRESSION; GENOME ANALYSIS; HUMAN; MICROARRAY ANALYSIS; REVIEW; SPLICEOSOME; TUMOR GENE;

ALTERNATIVE SPLICING; COMPUTATIONAL BIOLOGY; GENE EXPRESSION PROFILING; HUMANS; NEOPLASMS;

EID: 34447106755     PISSN: 13572725     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biocel.2007.02.016     Document Type: Review

References (144)

1. Aubol B.E., Chakrabarti S., Ngo J., Shaffer J., Nolen B., Fu X.D., et al. Processive phosphorylation of alternative splicing factor/splicing factor 2. Proceedings of the National Academy of Sciences of the United States of America 100 22 (2003) 12601-12606
2. Barnard D.C., Li J., Peng R., and Patton J.G. Regulation of alternative splicing by SRrp86 through coactivation and repression of specific SR proteins. RNA 8 4 (2002) 526-533
3. Barnard D.C., and Patton J.G. Identification and characterization of a novel serine-arginine-rich splicing regulatory protein. Molecular and Cellular Biology 20 9 (2000) 3049-3057
4. Batsche E., Yaniv M., and Muchardt C. The human SWI/SNF subunit brm is a regulator of alternative splicing. Nature Structural & Molecular Biology 13 1 (2006) 22-29
5. Beroud C., Hamroun D., Collod-Beroud G., Boileau C., Soussi T., and Claustres M. UMD (universal mutation database): 2005 update. Human Mutation 26 3 (2005) 184-191
6. Blanchette M., Green R.E., Brenner S.E., and Rio D.C. Global analysis of positive and negative pre-mRNA splicing regulators in Drosophila. Genes and Development 19 11 (2005) 1306-1314
7. Bland C.S., and Cooper T.A. Micromanaging alternative splicing during muscle differentiation. Developmental Cell 12 2 (2007) 171-172
8. Blencowe B.J. Exonic splicing enhancers: Mechanism of action, diversity and role in human genetic diseases. Trends in Biochemical Sciences 25 3 (2000) 106-110
9. Blencowe B.J. Splicing regulation: The cell cycle connection. Current Biology 13 4 (2003) R149-R151
10. Blencowe B.J. Alternative splicing: New insights from global analyses. Cell 126 1 (2006) 37-47
11. Blencowe B.J., Bowman J.A., McCracken S., and Rosonina E. SR-related proteins and the processing of messenger RNA precursors. Biochemistry and Cell Biology 77 4 (1999) 277-291
12. Blencowe B.J., Issner R., Nickerson J.A., and Sharp P.A. A coactivator of pre-mRNA splicing. Genes & Development 12 7 (1998) 996-1009
13. Boutz P.L., Chawla G., Stoilov P., and Black D.L. MicroRNAs regulate the expression of the alternative splicing factor nPTB during muscle development. Genes & Development 21 1 (2007) 71-84
14. Brett D., Lehmann G., Hanke J., Gross S., Reich J., and Bork P. EST analysis online: WWW tools for detection of SNPs and alternative splice forms. Trends in Genetics 16 9 (2000) 416-418
15. Brinkman B.M. Splice variants as cancer biomarkers. Clinical Biochemistry 37 7 (2004) 584-594
16. Brzoska P.M., Brown C., Cassel M., Ceccardi T., Di Francisco V., Dubman A., et al. An efficient and high-throughput approach for experimental validation of novel human gene predictions. Genomics 87 4 (2006) 437-445
17. Caceres J.F., Screaton G.R., and Krainer A.R. A specific subset of SR proteins shuttles continuously between the nucleus and the cytoplasm. Genes & Development 12 1 (1998) 55-66
18. Calin G.A., and Croce C.M. MicroRNA signatures in human cancers. Nature Reviews Cancer 6 11 (2006) 857-866
19. Cartegni L., Wang J., Zhu Z., Zhang M.Q., and Krainer A.R. ESEfinder: A web resource to identify exonic splicing enhancers. Nucleic Acids Research 31 13 (2003) 3568-3571
20. Castle J., Garrett-Engele P., Armour C.D., Duenwald S.J., Loerch P.M., Meyer M.R., et al. Optimization of oligonucleotide arrays and RNA amplification protocols for analysis of transcript structure and alternative splicing. Genome Biology 4 10 (2003) R66
21. Chalfant C.E., Rathman K., Pinkerman R.L., Wood R.E., Obeid L.M., Ogretmen B., et al. De novo ceramide regulates the alternative splicing of caspase 9 and bcl-x in A549 lung adenocarcinoma cells. Dependence on protein phosphatase-1. The Journal of Biological Chemistry 277 15 (2002) 12587-12595
22. Cheng C., and Sharp P.A. Regulation of CD44 alternative splicing by SRm160 and its potential role in tumor cell invasion. Molecular and Cellular Biology 26 1 (2006) 362-370
23. Cheng C., Yaffe M.B., and Sharp P.A. A positive feedback loop couples ras activation and CD44 alternative splicing. Genes & Development 20 13 (2006) 1715-1720
24. Colwill K., Feng L.L., Yeakley J.M., Gish G.D., Caceres J.F., Pawson T., et al. SRPK1 and Clk/Sty protein kinases show distinct substrate specificities for serine/arginine-rich splicing factors. The Journal of Biological Chemistry 271 40 (1996) 24569-24575
25. Cuperlovic-Culf M., Belacel N., Culf A.S., and Ouellette R.J. Microarray analysis of alternative splicing. Omics 10 3 (2006) 344-357
26. Daoud R., Mies G., Smialowska A., Olah L., Hossmann K.A., and Stamm S. Ischemia induces a translocation of the splicing factor tra2-beta 1 and changes alternative splicing patterns in the brain. The Journal of Neuroscience 22 14 (2002) 5889-5899
27. Ding J.H., Xu X., Yang D., Chu P.H., Dalton N.D., Ye Z., et al. Dilated cardiomyopathy caused by tissue-specific ablation of SC35 in the heart. The EMBO Journal 23 4 (2004) 885-896
28. ElSharawy A., Manaster C., Teuber M., Rosenstiel P., Kwiatkowski R., Huse K., et al. SNPSplicer: Systematic analysis of SNP-dependent splicing in genotyped cDNAs. Human Mutation 27 11 (2006) 1129-1134
29. Fairbrother W.G., Holste D., Burge C.B., and Sharp P.A. Single nucleotide polymorphism-based validation of exonic splicing enhancers. PLoS Biology 2 9 (2004) E268
30. Fehlbaum P., Guihal C., Bracco L., and Cochet O. A microarray configuration to quantify expression levels and relative abundance of splice variants. Nucleic Acids Research 33 5 (2005) e47
31. Fischer D.C., Noack K., Runnebaum I.B., Watermann D.O., Kieback D.G., Stamm S., et al. Expression of splicing factors in human ovarian cancer. Oncology Reports 11 5 (2004) 1085-1090
32. Forch P., and Valcarcel J. Molecular mechanisms of gene expression regulation by the apoptosis-promoting protein TIA-1. Apoptosis 6 6 (2001) 463-468
33. Forrest A.R., Taylor D.F., Crowe M.L., Chalk A.M., Waddell N.J., Kolle G., et al. Genome-wide review of transcriptional complexity in mouse protein kinases and phosphatases. Genome Biology 7 1 (2006) R5
34. Galiana-Arnoux D., Lejeune F., Gesnel M.C., Stevenin J., Breathnach R., and Del Gatto-Konczak F. The CD44 alternative v9 exon contains a splicing enhancer responsive to the SR proteins 9G8, ASF/SF2, and SRp20. The Journal of Biological Chemistry 278 35 (2003) 32943-32953
35. Gardina P.J., Clark T.A., Shimada B., Staples M.K., Yang Q., Veitch J., et al. Alternative splicing and differential gene expression in colon cancer detected by a whole genome exon array. BMC Genomics 7 (2006) 325
36. Graveley B.R. Mutually exclusive splicing of the insect dscam pre-mRNA directed by competing intronic RNA secondary structures. Cell 123 1 (2005) 65-73
37. Graveley B.R., Hertel K.J., and Maniatis T. A systematic analysis of the factors that determine the strength of pre-mRNA splicing enhancers. The EMBO Journal 17 22 (1998) 6747-6756
38. Green R.E., Lewis B.P., Hillman R.T., Blanchette M., Lareau L.F., Garnett A.T., et al. Widespread predicted nonsense-mediated mRNA decay of alternatively-spliced transcripts of human normal and disease genes. Bioinformatics 19 Suppl. 1 (2003) i118-i121
39. Gromak N., Matlin A.J., Cooper T.A., and Smith C.W. Antagonistic regulation of alpha-actinin alternative splicing by CELF proteins and polypyrimidine tract binding protein. RNA 9 4 (2003) 443-456
40. Gui J.F., Lane W.S., and Fu X.D. A serine kinase regulates intracellular localization of splicing factors in the cell cycle. Nature 369 6482 (1994) 678-682
41. Gupta S., Zink D., Korn B., Vingron M., and Haas S.A. Genome wide identification and classification of alternative splicing based on EST data. Bioinformatics 20 16 (2004) 2579-2585
42. Gupta S., Zink D., Korn B., Vingron M., and Haas S.A. Strengths and weaknesses of EST-based prediction of tissue-specific alternative splicing. BMC Genomics 5 1 (2004) 72
43. Hanahan D., and Weinberg R.A. The hallmarks of cancer. Cell 100 1 (2000) 57-70
44. Hanamura A., Caceres J.F., Mayeda A., Franza Jr. B.R., and Krainer A.R. Regulated tissue-specific expression of antagonistic pre-mRNA splicing factors. RNA 4 4 (1998) 430-444
45. Hanke J., Brett D., Zastrow I., Aydin A., Delbruck S., Lehmann G., et al. Alternative splicing of human genes: More the rule than the exception?. Trends in Genetics 15 10 (1999) 389-390
46. Hastings M.L., Resta N., Traum D., Stella A., Guanti G., and Krainer A.R. An LKB1 AT-AC intron mutation causes peutz-jeghers syndrome via splicing at noncanonical cryptic splice sites. Nature Structural & Molecular Biology 12 1 (2005) 54-59
47. He X., Ee P.L., Coon J.S., and Beck W.T. Alternative splicing of the multidrug resistance protein 1/ATP binding cassette transporter subfamily gene in ovarian cancer creates functional splice variants and is associated with increased expression of the splicing factors PTB and SRp20. Clinical Cancer Research 10 14 (2004) 4652-4660
48. Heider K.H., Kuthan H., Stehle G., and Munzert G. CD44v6: A target for antibody-based cancer therapy. Cancer Immunology, Immunotherapy 53 7 (2004) 567-579
49. Herrlich P., Morrison H., Sleeman J., Orian-Rousseau V., Konig H., Weg-Remers S., et al. CD44 acts both as a growth- and invasiveness-promoting molecule and as a tumor-suppressing cofactor. Annals of the New York Academy of Sciences 910 (2000) 106-118 discussion 118-120
50. Huang H.Y., Chien C.H., Jen K.H., and Huang H.D. RegRNA: An integrated web server for identifying regulatory RNA motifs and elements. Nucleic Acids Research 34 Web Server issue (2006) W429-W434
51. Huang H.D., Horng J.T., Lin F.M., Chang Y.C., and Huang C.C. SpliceInfo: An information repository for mRNA alternative splicing in human genome. Nucleic Acids Research 33 Database issue (2005) D80-D85
52. Huusko P., Ponciano-Jackson D., Wolf M., Kiefer J.A., Azorsa D.O., Tuzmen S., et al. Nonsense-mediated decay microarray analysis identifies mutations of EPHB2 in human prostate cancer. Nature Genetics 36 9 (2004) 979-983
53. International Human Genome Sequencing Consortium. Finishing the euchromatic sequence of the human genome. Nature 431 7011 (2004) 931-945
54. Izquierdo J.M., Majos N., Bonnal S., Martinez C., Castelo R., Guigo R., et al. Regulation of fas alternative splicing by antagonistic effects of TIA-1 and PTB on exon definition. Molecular Cell 19 4 (2005) 475-484
55. Izquierdo J.M., and Valcarcel J. Fas-activated serine/threonine kinase (FAST K) synergizes with TIA-1/TIAR proteins to regulate fas alternative splicing. Journal of Biological Chemistry 282 3 (2006) 1539-1543
56. Johnson J.M., Castle J., Garrett-Engele P., Kan Z., Loerch P.M., Armour C.D., et al. Genome-wide survey of human alternative pre-mRNA splicing with exon junction microarrays. Science 302 5653 (2003) 2141-2144
57. Jurica M.S., Licklider L.J., Gygi S.R., Grigorieff N., and Moore M.J. Purification and characterization of native spliceosomes suitable for three-dimensional structural analysis. RNA 8 4 (2002) 426-439
58. Jurica M.S., and Moore M.J. Pre-mRNA splicing: Awash in a sea of proteins. Molecular Cell 12 1 (2003) 5-14
59. Kaller M., Lundeberg J., and Ahmadian A. Arrayed identification of DNA signatures. Expert Review of Molecular Diagnostics 7 1 (2007) 65-76
60. Kalnina Z., Zayakin P., Silina K., and Line A. Alterations of pre-mRNA splicing in cancer. Genes, Chromosomes & Cancer 42 4 (2005) 342-357
61. Katsarou M.E., Papakyriakou A., Katsaros N., and Scorilas A. Expression of the C-terminal domain of novel human SR-A1 protein: Interaction with the CTD domain of RNA polymerase II. Biochemical and Biophysical Research Communications 334 1 (2005) 61-68
62. Kirschbaum-Slager N., Lopes G.M., Galante P.A., Riggins G.J., and de Souza S.J. Splicing factors are differentially expressed in tumors. Genetics and Molecular Research 3 4 (2004) 512-520
63. König H., Moll J., Ponta H., and Herrlich P. Trans-acting factors regulate the expression of CD44 splice variants. The EMBO journal 15 15 (1996) 4030-4039
64. Kuroyanagi N., Onogi H., Wakabayashi T., and Hagiwara M. Novel SR-protein-specific kinase, SRPK2, disassembles nuclear speckles. Biochemical and Biophysical Research Communications 242 2 (1998) 357-364
65. Ladd A.N., Charlet N., and Cooper T.A. The CELF family of RNA binding proteins is implicated in cell-specific and developmentally regulated alternative splicing. Molecular and Cellular Biology 21 4 (2001) 1285-1296
66. Le K., Mitsouras K., Roy M., Wang Q., Xu Q., Nelson S.F., et al. Detecting tissue-specific regulation of alternative splicing as a qualitative change in microarray data. Nucleic Acids Research 32 22 (2004) e180
67. Lee C., and Roy M. Analysis of alternative splicing with microarrays: Successes and challenges. Genome Biology 5 7 (2004) 231
68. Lemischka I.R., and Pritsker M. Alternative splicing increases complexity of stem cell transcriptome. Cell Cycle 5 4 (2006) 347-351
69. Lewis B.P., Green R.E., and Brenner S.E. Evidence for the widespread coupling of alternative splicing and nonsense-mediated mRNA decay in humans. Proceedings of the National Academy of Sciences of the United States of America 100 1 (2003) 189-192
70. Li J., Hawkins I.C., Harvey C.D., Jennings J.L., Link A.J., and Patton J.G. Regulation of alternative splicing by SRrp86 and its interacting proteins. Molecular and Cellular Biology 23 21 (2003) 7437-7447
71. Li C., Kato M., Shiue L., Shively J.E., Ares Jr. M., and Lin R.J. Cell type and culture condition-dependent alternative splicing in human breast cancer cells revealed by splicing-sensitive microarrays. Cancer Research 66 4 (2006) 1990-1999
72. Li H.R., Wang-Rodriguez J., Nair T.M., Yeakley J.M., Kwon Y.S., Bibikova M., et al. Two-dimensional transcriptome profiling: Identification of messenger RNA isoform signatures in prostate cancer from archived paraffin-embedded cancer specimens. Cancer Research 66 8 (2006) 4079-4088
73. Maniatis T., and Reed R. An extensive network of coupling among gene expression machines. Nature 416 6880 (2002) 499-506
74. Margulies M., Egholm M., Altman W.E., Attiya S., Bader J.S., Bemben L.A., et al. Genome sequencing in microfabricated high-density picolitre reactors. Nature 437 7057 (2005) 376-380
75. Marin-Vinader L., Shin C., Onnekink C., Manley J.L., and Lubsen N.H. Hsp27 enhances recovery of splicing as well as rephosphorylation of SRp38 after heat shock. Molecular Biology of the Cell 17 2 (2006) 886-894
76. Mathioudaki K., Leotsakou T., Papadokostopoulou A., Paraskevas E., Ardavanis A., Talieri M., et al. SR-A1, a member of the human pre-mRNA splicing factor family, and its expression in colon cancer progression. Biological Chemistry 385 9 (2004) 785-790
77. Matter N., Herrlich P., and Konig H. Signal-dependent regulation of splicing via phosphorylation of Sam68. Nature 420 6916 (2002) 691-695
78. Matter N., Marx M., Weg-Remers S., Ponta H., Herrlich P., and Konig H. Heterogeneous ribonucleoprotein A1 is part of an exon-specific splice-silencing complex controlled by oncogenic signaling pathways. The Journal of Biological Chemistry 275 45 (2000) 35353-35360
79. McGarvey T., Rosonina E., McCracken S., Li Q., Arnaout R., Mientjes E., et al. The acute myeloid leukemia-associated protein, DEK, forms a splicing-dependent interaction with exon-product complexes. The Journal of Cell Biology 150 2 (2000) 309-320
80. Mendell J.T., Sharifi N.A., Meyers J.L., Martinez-Murillo F., and Dietz H.C. Nonsense surveillance regulates expression of diverse classes of mammalian transcripts and mutes genomic noise. Nature Genetics 36 10 (2004) 1073-1078
81. Mironov A.A., Fickett J.W., and Gelfand M.S. Frequent alternative splicing of human genes. Genome Research 9 12 (1999) 1288-1293
82. Misteli T., Caceres J.F., Clement J.Q., Krainer A.R., Wilkinson M.F., and Spector D.L. Serine phosphorylation of SR proteins is required for their recruitment to sites of transcription in vivo. The Journal of Cell Biology 143 2 (1998) 297-307
83. Misteli T., Caceres J.F., and Spector D.L. The dynamics of a pre-mRNA splicing factor in living cells. Nature 387 6632 (1997) 523-527
84. Narla G., Difeo A., Reeves H.L., Schaid D.J., Hirshfeld J., Hod E., et al. A germline DNA polymorphism enhances alternative splicing of the KLF6 tumor suppressor gene and is associated with increased prostate cancer risk. Cancer Research 65 4 (2005) 1213-1222
85. Narla G., DiFeo A., Yao S., Banno A., Hod E., Reeves H.L., et al. Targeted inhibition of the KLF6 splice variant, KLF6 SV1, suppresses prostate cancer cell growth and spread. Cancer Research 65 13 (2005) 5761-5768
86. Nilsen T.W. The spliceosome: No assembly required?. Molecular Cell 9 1 (2002) 8-9
87. Nilsen T.W. The spliceosome: The most complex macromolecular machine in the cell?. BioEssays 25 12 (2003) 1147-1149
88. Orban T.I., and Olah E. Emerging roles of BRCA1 alternative splicing. Molecular Pathology 56 4 (2003) 191-197
89. Pan Q., Bakowski M.A., Morris Q., Zhang W., Frey B.J., Hughes T.R., et al. Alternative splicing of conserved exons is frequently species-specific in human and mouse. Trends in Genetics 21 2 (2005) 73-77
90. Pan Q., Saltzman A.L., Kim Y.K., Misquitta C., Shai O., Maquat L.E., et al. Quantitative microarray profiling provides evidence against widespread coupling of alternative splicing with nonsense-mediated mRNA decay to control gene expression. Genes & Development 20 2 (2006) 153-158
91. Pan Q., Shai O., Misquitta C., Zhang W., Saltzman A.L., Mohammad N., et al. Revealing global regulatory features of mammalian alternative splicing using a quantitative microarray platform. Molecular Cell 16 6 (2004) 929-941
92. Park J.W., Parisky K., Celotto A.M., Reenan R.A., and Graveley B.R. Identification of alternative splicing regulators by RNA interference in drosophila. Proceedings of the National Academy of Sciences of the United States of America 101 45 (2004) 15974-15979
93. Pind M.T., and Watson P.H. SR protein expression and CD44 splicing pattern in human breast tumours. Breast Cancer Research and Treatment 79 1 (2003) 75-82
94. Pritsker M., Doniger T.T., Kramer L.C., Westcot S.E., and Lemischka I.R. Diversification of stem cell molecular repertoire by alternative splicing. Proceedings of the National Academy of Sciences of the United States of America 102 40 (2005) 14290-14295
95. Pritsker M., Ford N.R., Jenq H.T., and Lemischka I.R. Genomewide gain-of-function genetic screen identifies functionally active genes in mouse embryonic stem cells. Proceedings of the National Academy of Sciences of the United States of America 103 18 (2006) 6946-6951
96. Raffetseder U., Frye B., Rauen T., Jurchott K., Royer H.D., Jansen P.L., et al. Splicing factor SRp30c interaction with Y-box protein-1 confers nuclear YB-1 shuttling and alternative splice site selection. The Journal of Biological Chemistry 278 20 (2003) 18241-18248
97. Rappsilber J., Ryder U., Lamond A.I., and Mann M. Large-scale proteomic analysis of the human spliceosome. Genome Research 12 8 (2002) 1231-1245
98. Relogio A., Ben-Dov C., Baum M., Ruggiu M., Gemund C., Benes V., et al. Alternative splicing microarrays reveal functional expression of neuron-specific regulators in hodgkin lymphoma cells. The Journal of Biological Chemistry 280 6 (2005) 4779-4784
99. Renshaw J., Orr R.M., Walton M.I., Te Poele R., Williams R.D., Wancewicz E.V., et al. Disruption of WT1 gene expression and exon 5 splicing following cytotoxic drug treatment: Antisense down-regulation of exon 5 alters target gene expression and inhibits cell survival. Molecular Cancer Therapeutics 3 11 (2004) 1467-1484
100. Resch A., Xing Y., Alekseyenko A., Modrek B., and Lee C. Evidence for a subpopulation of conserved alternative splicing events under selection pressure for protein reading frame preservation. Nucleic Acids Research 32 4 (2004) 1261-1269
101. Rosonina E., and Blencowe B.J. Gene expression: The close coupling of transcription and splicing. Current Biology 12 9 (2002) R319-R321
102. Rosonina E., and Blencowe B.J. Analysis of the requirement for RNA polymerase II CTD heptapeptide repeats in pre-mRNA splicing and 3′-end cleavage. RNA 10 4 (2004) 581-589
103. Rosonina E., Ip J.Y., Calarco J.A., Bakowski M.A., Emili A., McCracken S., et al. Role for PSF in mediating transcriptional activator-dependent stimulation of pre-mRNA processing in vivo. Molecular and Cellular Biology 25 15 (2005) 6734-6746
104. Roy M., Xu Q., and Lee C. Evidence that public database records for many cancer-associated genes reflect a splice form found in tumors and lack normal splice forms. Nucleic Acids Research 33 16 (2005) 5026-5033
105. Salesse S., Dylla S.J., and Verfaillie C.M. p210BCR/ABL-induced alteration of pre-mRNA splicing in primary human CD34+ hematopoietic progenitor cells. Leukemia 18 4 (2004) 727-733
106. Sampath J., Long P.R., Shepard R.L., Xia X., Devanarayan V., Sandusky G.E., et al. Human SPF45, a splicing factor, has limited expression in normal tissues, is overexpressed in many tumors, and can confer a multidrug-resistant phenotype to cells. The American Journal of Pathology 163 5 (2003) 1781-1790
107. Shai O., Morris Q.D., Blencowe B.J., and Frey B.J. Inferring global levels of alternative splicing isoforms using a generative model of microarray data. Bioinformatics 22 5 (2006) 606-613
108. Shin C., Feng Y., and Manley J.L. Dephosphorylated SRp38 acts as a splicing repressor in response to heat shock. Nature 427 6974 (2004) 553-558
109. Shin C., Kleiman F.E., and Manley J.L. Multiple properties of the splicing repressor SRp38 distinguish it from typical SR proteins. Molecular and Cellular Biology 25 18 (2005) 8334-8343
110. Shin C., and Manley J.L. The SR protein SRp38 represses splicing in M phase cells. Cell 111 3 (2002) 407-417
111. Shoemaker D.D., Schadt E.E., Armour C.D., He Y.D., Garrett-Engele P., McDonagh P.D., et al. Experimental annotation of the human genome using microarray technology. Nature 409 6822 (2001) 922-927
112. Soret J., Gabut M., Dupon C., Kohlhagen G., Stevenin J., Pommier Y., et al. Altered serine/arginine-rich protein phosphorylation and exonic enhancer-dependent splicing in mammalian cells lacking topoisomerase I. Cancer Research 63 23 (2003) 8203-8211
113. Spellman R., Rideau A., Matlin A., Gooding C., Robinson F., McGlincy N., et al. Regulation of alternative splicing by PTB and associated factors. Biochemical Society Transactions 33 Pt 3 (2005) 457-460
114. Stamm S., Riethoven J.J., Le Texier V., Gopalakrishnan C., Kumanduri V., Tang Y., et al. ASD: A bioinformatics resource on alternative splicing. Nucleic Acids Research 34 Database issue (2006) D46-D55
115. Stickeler E., Fraser S.D., Honig A., Chen A.L., Berget S.M., and Cooper T.A. The RNA binding protein YB-1 binds A/C-rich exon enhancers and stimulates splicing of the CD44 alternative exon v4. The EMBO Journal 20 14 (2001) 3821-3830
116. Stoss O., Olbrich M., Hartmann A.M., Konig H., Memmott J., Andreadis A., et al. The STAR/GSG family protein rSLM-2 regulates the selection of alternative splice sites. The Journal of Biological Chemistry 276 12 (2001) 8665-8673
117. Thill G., Castelli V., Pallud S., Salanoubat M., Wincker P., de la Grange P., et al. ASEtrap: A biological method for speeding up the exploration of spliceomes. Genome Research 16 6 (2006) 776-786
118. Tian M., and Maniatis T. A splicing enhancer exhibits both constitutive and regulated activities. Genes & Development 8 14 (1994) 1703-1712
119. Ule J., Ule A., Spencer J., Williams A., Hu J.S., Cline M., et al. Nova regulates brain-specific splicing to shape the synapse. Nature Genetics 37 8 (2005) 844-852
120. Vegran F., Boidot R., Oudin C., Riedinger J.M., Bonnetain F., and Lizard-Nacol S. Overexpression of caspase-3s splice variant in locally advanced breast carcinoma is associated with poor response to neoadjuvant chemotherapy. Clinical Cancer Research 12 19 (2006) 5794-5800
121. Venables J.P. Aberrant and alternative splicing in cancer. Cancer Research 64 21 (2004) 7647-7654
122. Venables J.P. Unbalanced alternative splicing and its significance in cancer. BioEssays 28 4 (2006) 378-386
123. Venables J.P., Bourgeois C.F., Dalgliesh C., Kister L., Stevenin J., and Elliott D.J. Up-regulation of the ubiquitous alternative splicing factor Tra2beta causes inclusion of a germ cell-specific exon. Human Molecular Genetics 14 16 (2005) 2289-2303
124. Venables J.P., and Burn J. EASI-enrichment of alternatively spliced isoforms. Nucleic Acids Research 34 15 (2006) e103
125. Wang Z., Lo H.S., Yang H., Gere S., Hu Y., Buetow K.H., et al. Computational analysis and experimental validation of tumor-associated alternative RNA splicing in human cancer. Cancer Research 63 3 (2003) 655-657
126. Wang J., Smith P.J., Krainer A.R., and Zhang M.Q. Distribution of SR protein exonic splicing enhancer motifs in human protein-coding genes. Nucleic Acids Research 33 16 (2005) 5053-5062
127. Watermann D.O., Tang Y., Zur Hausen A., Jager M., Stamm S., and Stickeler E. Splicing factor Tra2-beta1 is specifically induced in breast cancer and regulates alternative splicing of the CD44 gene. Cancer Research 66 9 (2006) 4774-4780
128. Weg-Remers S., Ponta H., Herrlich P., and Konig H. Antagonistic signaling pathways regulate alternative splicing of CD44 in T cells. Annals of the New York Academy of Sciences 973 (2002) 112-115
129. Weg-Remers S., Ponta H., Herrlich P., and Konig H. Regulation of alternative pre-mRNA splicing by the ERK MAP-kinase pathway. The EMBO Journal 20 15 (2001) 4194-4203
130. Wolf M., Edgren H., Muggerud A., Kilpinen S., Huusko P., Sorlie T., et al. NMD microarray analysis for rapid genome-wide screen of mutated genes in cancer. Cellular Oncology 27 3 (2005) 169-173
131. Wollerton M.C., Gooding C., Wagner E.J., Garcia-Blanco M.A., and Smith C.W. Autoregulation of polypyrimidine tract binding protein by alternative splicing leading to nonsense-mediated decay. Molecular Cell 13 1 (2004) 91-100
132. Xing Y., Kapur K., and Wong W.H. Probe selection and expression index computation of affymetrix exon arrays. PLoS ONE 1 (2006) e88
133. Xing Y., and Lee C. Evidence of functional selection pressure for alternative splicing events that accelerate evolution of protein subsequences. Proceedings of the National Academy of Sciences of the United States of America 102 38 (2005) 13526-13531
134. Xing Y., and Lee C.J. Protein modularity of alternatively spliced exons is associated with tissue-specific regulation of alternative splicing. PLoS Genetics 1 3 (2005) e34
135. Xing Y., and Lee C. Alternative splicing and RNA selection pressure-Evolutionary consequences for eukaryotic genomes. Nature Reviews Genetics 7 7 (2006) 499-509
136. Xu Q., and Lee C. Discovery of novel splice forms and functional analysis of cancer-specific alternative splicing in human expressed sequences. Nucleic Acids Research 31 19 (2003) 5635-5643
137. Xu Q., Modrek B., and Lee C. Genome-wide detection of tissue-specific alternative splicing in the human transcriptome. Nucleic Acids Research 30 17 (2002) 3754-3766
138. Yeakley J.M., Fan J.B., Doucet D., Luo L., Wickham E., Ye Z., et al. Profiling alternative splicing on fiber-optic arrays. Nature Biotechnology 20 4 (2002) 353-358
139. Yeo G., Holste D., Kreiman G., and Burge C.B. Variation in alternative splicing across human tissues. Genome Biology 5 10 (2004) R74
140. Zerbe L.K., Pino I., Pio R., Cosper P.F., Dwyer-Nield L.D., Meyer A.M., et al. Relative amounts of antagonistic splicing factors, hnRNP A1 and ASF/SF2, change during neoplastic lung growth: Implications for pre-mRNA processing. Molecular Carcinogenesis 41 4 (2004) 187-196
141. Zhang C., Li H.R., Fan J.B., Wang-Rodriguez J., Downs T., Fu X.D., et al. Profiling alternatively spliced mRNA isoforms for prostate cancer classification. BMC Bioinformatics 7 (2006) 202
142. Zhang K., Zhu J., Shendure J., Porreca G.J., Aach J.D., Mitra R.D., et al. Long-range polony haplotyping of individual human chromosome molecules. Nature Genetics 38 3 (2006) 382-387
143. Zhou Z., Licklider L.J., Gygi S.P., and Reed R. Comprehensive proteomic analysis of the human spliceosome. Nature 419 6903 (2002) 182-185
144. Zhu J., Shendure J., Mitra R.D., and Church G.M. Single molecule profiling of alternative pre-mRNA splicing. Science 301 5634 (2003) 836-838